The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App 
Professionals >> Visit The Body PROThe Body en Espanol
  • Email Email
  • Comments Comments
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

Medical News

FDA Finds No Heart Attack Risk With HIV Drug

March 2, 2011

Food and Drug Administration officials said Tuesday that a data review of the AIDS drug abacavir revealed no greater risk of heart attacks than other HIV medicines. Doctors should continue to prescribe abacavir as directed, the agency said. FDA's analysis included 26 clinical trials and began in 2008 after studies showed conflicting information about a possible link to heart attacks. Abacavir, a nucleoside reverse transcriptase inhibitor, is in the combination treatments Ziagen, Trizivir, and Epzicom.

Back to other news for March 2011

Adapted from:

  • Email Email
  • Comments Comments
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.
See Also
More on HIV Medications
More News on Abacavir (Ziagen)

No comments have been made.

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read's Comment Policy.)

Your Name:

Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining: